aica ribonucleotide has been researched along with Acute Confusional Senile Dementia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Jiang, Y; Jin, R; Li, J; Li, Y; Shi, L; Yang, L; Zhong, D | 1 |
Cao, Y; Li, M; Li, MZ; Liu, BJ; Shi, FX; Sun, DS; Tian, Q; Wang, JZ; Wang, L; Xu, WQ; Zhou, XW | 1 |
Cao, L; Ji, L; Li, H; Mao, K; Sha, L; Tang, X; Wei, J; Wei, N; Wu, J; Xie, W; Yang, S; Yang, Z; Zhu, L | 1 |
Chai, DM; Du, LL; Li, XH; Liu, LB; Liu, R; Wang, JZ; Wu, K; Zhang, FC; Zhang, HB; Zhao, LN; Zhou, XW | 1 |
Ashford, JW; Casadesus, G; Greco, SJ; Johnston, JM; Sarkar, S; Smith, MA; Su, B; Tezapsidis, N; Zhu, X | 1 |
Greco, SJ; Johnston, JM; Sarkar, S; Tezapsidis, N | 1 |
Ashford, JW; Casadesus, G; Greco, SJ; Johnston, JM; Sarkar, S; Smith, MA; Tezapsidis, N; Zhu, X | 1 |
1 review(s) available for aica ribonucleotide and Acute Confusional Senile Dementia
Article | Year |
---|---|
AMPK: Potential Therapeutic Target for Alzheimer's Disease.
Topics: Alzheimer Disease; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Autophagy; Biphenyl Compounds; Clinical Trials as Topic; Gene Expression Regulation; Humans; Insulin Resistance; Mitochondria; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Pyrones; Ribonucleotides; tau Proteins; Thiophenes | 2020 |
6 other study(ies) available for aica ribonucleotide and Acute Confusional Senile Dementia
Article | Year |
---|---|
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Topics: Adenylate Kinase; Aging; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Cannabinoids; Enzyme Activation; Gene Deletion; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Phosphorylation; Receptor, Cannabinoid, CB2; Resveratrol; Ribonucleotides; Signal Transduction; tau Proteins | 2018 |
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Topics: Alzheimer Disease; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Fasting; Gene Expression Regulation; Glucose Tolerance Test; Humans; Insulin; Insulysin; Learning; Mice; Mice, Transgenic; PPAR gamma; Ribonucleotides; Rosiglitazone; Streptozocin; Thiazolidinediones | 2018 |
AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
Topics: Adenylate Kinase; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Caspase 3; Disease Models, Animal; Hippocampus; Hypoglycemic Agents; Male; Memory Disorders; Phosphorylation; Rats; Rats, Sprague-Dawley; Ribonucleotides; Spatial Memory; Streptozocin; tau Proteins | 2015 |
Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.
Topics: Alzheimer Disease; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line, Tumor; Humans; Insulin; Leptin; Multienzyme Complexes; Neurons; Phosphorylation; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Ribonucleotides; Signal Transduction; tau Proteins | 2008 |
Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.
Topics: Alzheimer Disease; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Amyloid beta-Peptides; Animals; Cells, Cultured; Humans; Leptin; Neurons; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Pyrimidines; Rats; Ribonucleotides; tau Proteins | 2009 |
Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
Topics: Alzheimer Disease; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antimanic Agents; Brain; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypoglycemic Agents; Leptin; Lithium Chloride; Neurofibrillary Tangles; Neurons; Phosphorylation; Ribonucleotides; Signal Transduction; tau Proteins; Tumor Cells, Cultured | 2009 |